Upcoming Events

OIS@AAO 2018
Risuteganib for the Treatment of DME

To be presented by Vicken Karageozian, MD, President & CEO
October 25, 2018
Marriott Marquis Chicago

American Academy of Ophthalmology Annual Meeting 2018
Randomized, Prospective, Double-Masked Controlled Phase 2b Trial on the Safety & Efficacy of Risuteganib (Luminate) for DME

Poster to be presented by Peter K. Kaiser, MD
October 29, 2018 12:45-1:45 pm (Poster displayed October 29-30)
McCormick Place, Chicago, South Hall A

View Past Events